DCT

1:24-cv-01013

Novo Nordisk Inc v. Mylan Pharma Inc

General

Filed

09/05/24

Cause of ActionPatent Infringement

SectorBiotech

StatusClosed

Patent Owner

Operating Company

PACER

Nature of Suit835 ANDA

Judge	Period	PO Win Rate
Colm F. Connolly	09/11/24 - 12/06/24	43%

Plaintiff

Party

Name	Ratings
Novo Nordisk Inc	L3 E
Novo Nordisk As NPE	L3 E

No Parties

Attorney

Name	Ratings
Morris Nichols Arsht & Tunnell LLPLocal	L5 A
Brian P. Egan	L5 A
Travis J. Murray	L1 E
Groombridge Wu Baughman Stone LLP	-- -- --
Nicholas Groombridge	L5 B
Jennifer H. Wu	L5 D
Josephine Young	L4 D
Daniel J. Klein	L3 B
Peter Sandel	L3 C
Joshua Reich	L1 B
Philip S. May	L1 B
Naz Wehrli	L1 C
Aileen C. Huang	-- -- --

No Attorneys

Defendant

Party

Name	Ratings
Mylan Pharmaceuticals Inc	L5 A

No Parties

Attorney

Name	Ratings
Stamoulis & Weinblatt	L3 D
Stamatios Stamoulis	L5 E

No Attorneys